A world-first personalised cancer vaccine is showing remarkable results in a global study of more than a thousand melanoma patients, led by Australian of the Year Professor Georgina Long. Paired with immunotherapy, it reduced the risk of recurrence or death by 42 per cent, and experts say it could be approved internationally within two years. Here’s how the mRNA technology works, and what it could mean for Australia, which has the highest rates of melanoma in the world.
His family confirmed he died of natural causes on Wednesday, remembering him for his humour, generosity and love of storytelling.
Join the conversation and follow us on:
X: https://x.com/10NewsAU
Facebook: http://www.facebook.com/10NewsAU/
Instagram: http://www.instagram.com/10NewsAU/
TikTok: https://www.tiktok.com/@10NewsAU
LinkedIn: https://www.linkedin.com/company/10newsau
10 News airs at 5pm, seven nights a week in your local market on Network 10.
Missed the bulletin? Catch up at https://10.com.au/news
10 News is based in Australia and is a division of Paramount.
source
Leave a Reply